Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays

Proteomics
Rongcai JiangWei Zhang

Abstract

The progression of gliomas has been extensively studied at the genomic level using cDNA microarrays. However, systematic examinations at the protein translational and post-translational levels are far more limited. We constructed a glioma protein lysate array from 82 different primary glioma tissues, and surveyed the expression and phosphorylation of 46 different proteins involved in signaling pathways of cell proliferation, cell survival, apoptosis, angiogenesis, and cell invasion. An analysis algorithm was employed to robustly estimate the protein expressions in these samples. When ranked by their discriminating power to separate 37 glioblastomas (high-grade gliomas) from 45 lower-grade gliomas, the following 12 proteins were identified as the most powerful discriminators: IBalpha, EGFRpTyr845, AKTpThr308, phosphatidylinositol 3-kinase (PI3K), BadpSer136, insulin-like growth factor binding protein (IGFBP) 2, IGFBP5, matrix metalloproteinase 9 (MMP9), vascular endothelial growth factor (VEGF), phosphorylated retinoblastoma protein (pRB), Bcl-2, and c-Abl. Clustering analysis showed a close link between PI3K and AKTpThr308, IGFBP5 and IGFBP2, and IBalpha and EGFRpTyr845. Another cluster includes MMP9, Bcl-2, VEGF, and pRB. Thes...Continue Reading

References

Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·P J ChiaoI M Verma
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·M P Scheid, V Duronio
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·D A TiceS J Parsons
Dec 28, 1999·Molecular and Cellular Biology·A SchürmannG M Bokoch
Feb 2, 2002·Nature·Laura J van 't VeerStephen H Friend
May 30, 2002·The British Journal of Mathematical and Statistical Psychology·H J KeselmanBurt Holland
Aug 12, 2003·Advances in Experimental Medicine and Biology·Daniel George
Nov 5, 2003·Proteomics·Virginia EspinaLance A Liotta
Nov 5, 2003·Proteomics·Robert L GrubbEmanuel F Petricoin
Nov 5, 2003·Proteomics·Markus F TemplinThomas O Joos
May 7, 2004·Nature·Lisa Melton
Jun 9, 2004·Laboratory Investigation; a Journal of Technical Methods and Pathology·Huamin WangGregory N Fuller
Jun 15, 2004·Brain Pathology·Wojciech BiernatHiroko Ohgaki
Jul 21, 2004·The Journal of Biological Chemistry·Jianhua FengBrian A Hemmings
Sep 15, 2004·The Journal of Biological Chemistry·Yuko KawakamiToshiaki Kawakami
Dec 21, 2004·Brain Pathology·Masahiro MizoguchiDavid N Louis
Jan 1, 2005·Trends in Neurosciences·Mollie K Meffert, David Baltimore
Jan 14, 2005·Bioinformatics·Cristian MirceanWei Zhang

❮ Previous
Next ❯

Citations

Dec 2, 2008·Journal of Neuro-oncology·Mia CarapanceaAnica Dricu
Jun 30, 2007·Bioinformatics·Jianhua HuGordon B Mills
Apr 2, 2009·Bioinformatics·E Shannon NeeleyKeith A Baggerly
Aug 20, 2011·Neuro-oncology·Juliya KalininaErwin G Van Meir
Dec 25, 2010·Proteome Science·Heiko A MannspergerUlrike Korf
May 3, 2012·Cancer Informatics·E Shannon NeeleySteven M Kornblau
Aug 14, 2013·Annual Review of Pathology·Timothy F CloughesyPaul S Mischel
Jun 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lin YangJann N Sarkaria
Apr 10, 2010·Expert Review of Proteomics·Kant M MatsudaStephen M Hewitt
Jul 17, 2014·International Immunopharmacology·Lisheng GeMartin R Jadus
Jun 19, 2012·Seminars in Cell & Developmental Biology·Hong Zhang, Steven Pelech
Mar 25, 2010·Journal of Proteomics·Simone P NiclouUros Rajcevic
Jan 12, 2008·Current Opinion in Biotechnology·Satoshi Nishizuka, Brett Spurrier
Mar 23, 2007·Biomolecular Engineering·Ronny FalkSophia Hober
Oct 1, 2009·Proteomics. Clinical Applications·Ulrike KorfAnnemarie Poustka
Dec 3, 2008·International Journal of Cancer. Journal International Du Cancer·Takashi ShinguSeiji Kondo
Sep 1, 2007·Proteomics. Clinical Applications·Harvey B PollardCloud P Paweletz
Jul 20, 2007·Proteomics·Oda Stoevesandt, Michael J Taussig
Feb 24, 2010·Brain Pathology·Ruth F DeightonIan R Whittle
Oct 27, 2010·Molecular Oncology·Claudius MuellerVirginia Espina
May 5, 2016·Molecular & Cellular Proteomics : MCP·Lindsay C StetsonJill S Barnholtz-Sloan
Jun 22, 2016·Oncotarget·Jasmina S RedzicMichael W Graner
Jun 1, 2010·Journal of Neuro-oncology·Paula KinsellaVerena Amberger-Murphy
Jul 16, 2017·International Journal of Cancer. Journal International Du Cancer·Mehmet BaysanHoward A Fine
May 27, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Vani SantoshManchanahalli R S Rao
Feb 20, 2021·Frontiers in Oncology·Elena TirròPaolo Vigneri
Oct 10, 2007·Archives of Pathology & Laboratory Medicine·Roger E McLendonJeremy Rich
Jun 15, 2007·Journal of Proteome Research·Kanchana Natarajan MendesWei Zhang
Oct 22, 2009·Science Signaling·Taranjit S Gujral, Gavin MacBeath
Dec 25, 2019·Experimental and Molecular Pathology·Gurjeet KaurYung Jen Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.